A detailed history of Childress Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 6,623 shares of ABBV stock, worth $1.16 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
6,623
Previous 6,502 1.86%
Holding current value
$1.16 Million
Previous $1.12 Million 17.22%
% of portfolio
0.36%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $19,824 - $24,118
121 Added 1.86%
6,623 $1.31 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $21,361 - $24,944
138 Added 2.17%
6,502 $1.12 Million
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $74,476 - $84,858
-466 Reduced 6.82%
6,364 $1.16 Million
Q4 2023

Feb 16, 2024

BUY
$137.6 - $154.97 $34,537 - $38,897
251 Added 3.82%
6,830 $1.06 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $878,888 - $1.02 Million
6,579 New
6,579 $980,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $726,520 - $836,696
-5,024 Reduced 70.3%
2,123 $338,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $73,442 - $88,076
531 Added 8.03%
7,147 $1.16 Million
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $28,184 - $32,325
-210 Reduced 3.08%
6,616 $899,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $40,322 - $51,263
293 Added 4.48%
6,826 $1.05 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $16,497 - $20,468
125 Added 1.95%
6,533 $1.06 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $177,796 - $224,964
-1,655 Reduced 20.53%
6,408 $868,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $416,343 - $472,612
3,913 Added 94.29%
8,063 $869,000
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $390,434 - $434,966
-3,711 Reduced 47.21%
4,150 $467,000
Q1 2021

May 21, 2021

BUY
$102.3 - $112.62 $258,307 - $284,365
2,525 Added 47.32%
7,861 $850,000
Q4 2020

Mar 09, 2021

BUY
$80.49 - $108.67 $429,494 - $579,863
5,336 New
5,336 $574,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Childress Capital Advisors, LLC Portfolio

Follow Childress Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.